# Efficacy of Fluoxetine - a Trial in Stroke

Study · id `cardio:ct-nct02683213` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02683213](<https://clinicaltrials.gov/study/NCT02683213>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02683213

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1500 participants.

## Technical summary

Registry record NCT02683213. Randomized; quadruple masking; primary purpose treatment. Start 2014-10-20 (actual); primary completion 2020-06 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 1500 participants (enrolled count; ClinicalTrials.gov record NCT02683213, source copy `cardio:ctgov-nct02683213-2020-09-02`, retrieved 2026-10-26)
- Started: 2014-10-20 (actual) (ClinicalTrials.gov record NCT02683213, source copy `cardio:ctgov-nct02683213-2020-09-02`, retrieved 2026-10-26)
- Primary completion: 2020-06 (actual) (ClinicalTrials.gov record NCT02683213, source copy `cardio:ctgov-nct02683213-2020-09-02`, retrieved 2026-10-26)
- Completion: 2020-06 (actual) (ClinicalTrials.gov record NCT02683213, source copy `cardio:ctgov-nct02683213-2020-09-02`, retrieved 2026-10-26)
- Countries: Sweden (ClinicalTrials.gov record NCT02683213, source copy `cardio:ctgov-nct02683213-2020-09-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02683213-2020-09-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy of Fluoxetine - a Trial in Stroke
- Acronym: EFFECTS
- Condition: Stroke
- Intervention (Drug): Fluoxetine
- Intervention (Drug): Placebo
- Lead sponsor: Karolinska Institutet
- Lead sponsor class: OTHER
- Collaborator: The Swedish Research Council
- Collaborator class: OTHER\_GOV
- Collaborator: Swedish Heart Lung Foundation
- Collaborator class: OTHER
- Collaborator: Stroke-Riksförbundet
- Collaborator class: UNKNOWN
- Collaborator: Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse
- Collaborator class: UNKNOWN
- Collaborator: Hjärnfonden (The Swedish Brain foundation)
- Collaborator class: UNKNOWN
- Collaborator: The Swedish Medical Association
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Karolinska Institutet (`cardio:org-karolinska-institutet`)
- Registry lists this organization as a collaborator: The Swedish Research Council (`cardio:org-the-swedish-research-council`)
- Registry lists this organization as a collaborator: Swedish Heart Lung Foundation (`cardio:org-swedish-heart-lung-foundation`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial (`cardio:pubmed-32702335`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of Fluoxetine on Outcomes at 12 Months After Acute Stroke: Results From EFFECTS, a Randomized Controlled Trial (`cardio:pubmed-34465201`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 2c6a89fe1984ffd0b4d178cb9a09eb1fbc504ba7aa4e9fd62f88d678dd52fac2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
